Biotechs Need To Be More Differentiated To Succeed, E&Y Reports
This article was originally published in The Pink Sheet Daily
Executive Summary
The 25th annual Ernst & Young report shows that biotechs have fewer exit strategies than ever and that pre-clinical stage companies still have a hard time finding financing.